Claudio Pulito

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Bridging phenotype and function in bladder cancer using immuno-competent organoids and ex vivo drug screening.

Bridging phenotype and function in bladder cancer using immuno-competent organoids and ex vivo drug screening.

Journal: Journal of experimental & clinical cancer research : CR

Published: October 14, 2025

Dissecting endometrial cancer complexity in response to standard and targeted therapies.

Dissecting endometrial cancer complexity in response to standard and targeted therapies.

Journal: Cell death & disease

Published: July 09, 2025

AATF supports proliferation of glioblastoma cells by sustaining mitochondrial respiration through an NRF-1-dependent mechanism.

AATF supports proliferation of glioblastoma cells by sustaining mitochondrial respiration through an NRF-1-dependent mechanism.

Journal: Cell death & disease

Published: June 27, 2025

Circulating miR-18b-3p is a novel biomarker predicting chemo-radiotherapy induced oral mucositis in head and neck cancer.

Circulating miR-18b-3p is a novel biomarker predicting chemo-radiotherapy induced oral mucositis in head and neck cancer.

Journal: Signal transduction and targeted therapy

Published: June 17, 2025

MicroRNA-mediated PTEN downregulation as a novel non-genetic mechanism of acquired resistance to PI3Kα inhibitors of head & neck squamous cell carcinoma.

MicroRNA-mediated PTEN downregulation as a novel non-genetic mechanism of acquired resistance to PI3Kα inhibitors of head & neck squamous cell carcinoma.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: February 06, 2025

CircPVT1 weakens miR-33a-5p unleashing the c-MYC/GLS1 metabolic axis in breast cancer.

CircPVT1 weakens miR-33a-5p unleashing the c-MYC/GLS1 metabolic axis in breast cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 08, 2025

The oncogenic axis YAP/MYC/EZH2 impairs PTEN tumor suppression activity enhancing lung tumorigenicity.

The oncogenic axis YAP/MYC/EZH2 impairs PTEN tumor suppression activity enhancing lung tumorigenicity.

Journal: Cell death discovery

Published: September 04, 2024

Author Correction: Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activities.

Author Correction: Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activities.

Journal: Cell discovery

Published: March 14, 2024

Targeting of mutant-p53 and MYC as a novel strategy to inhibit oncogenic SPAG5 activity in triple negative breast cancer.

Targeting of mutant-p53 and MYC as a novel strategy to inhibit oncogenic SPAG5 activity in triple negative breast cancer.

Journal: Cell death & disease

Published: March 08, 2024

Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patients.

Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patients.

Journal: Molecular cancer

Published: September 24, 2023

DARPP-32 and t-DARPP in the development of resistance to anti-HER2 agents. Pre-clinical evidence from the STEP study.

DARPP-32 and t-DARPP in the development of resistance to anti-HER2 agents. Pre-clinical evidence from the STEP study.

Journal: Neoplasia (New York, N.Y.)

Published: September 13, 2023

Exploiting Long Non-Coding RNAs and Circular RNAs as Pharmacological Targets in Triple-Negative Breast Cancer Treatment.

Exploiting Long Non-Coding RNAs and Circular RNAs as Pharmacological Targets in Triple-Negative Breast Cancer Treatment.

Journal: Cancers

Published: July 04, 2023

Showing 1-12 of 48

Last Updated: 09/26/2026